Cel Sci Corporation (CVM)

[lux1]

likely not rocket science here, but Interleukins are natural compound strongly involved in immuno-response against tumors and in past trials as single agents they showed some effectiveness.
Leukocyte Interleukin injection are also tested in H&N in a P2 by another Co, IRX Therapeutics and showed effectiveness:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5300054/figure/F6/
This trial and this drug is a pretty perfect copy of the CVM trial and of Multikine, and they spent several tens of million for the Co and for the trials, which prove that there is something of interesting in this choice.
https://clinicaltrials.gov/ct2/show/NCT02609386

Obviously it's extremely hard to know how close is CVM trial to 10% of reduction, by inference, it seems that they would be safe with a 6% ,having regard to their request submitted to the FDA. How conservative was it?

IMO: I hope that also a reduction around 6-9% (that is not a poor result in cancer!) could lead to a negotiation with FDA.